Navigation Links
New Drug May Help Immune System Fight Cancer
Date:5/16/2013

By Brenda Goodman
HealthDay Reporter

THURSDAY, May 16 (HealthDay News) -- An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.

The drug binds to a protein called PD-L1 that sits on the surface of cancer cells and makes them invisible to the immune system, almost like a cloaking device.

"That [the protein] allows the tumor cell to grow unchecked and cause harm to the patient," said study author Dr. Roy Herbst, chief of medical oncology at Yale University.

But with the protein blocked, the immune system can see and destroy cancer cells.

Of 140 patients in the pilot safety study, 29 (or 21 percent) initially saw significant tumor shrinkage after at least three months on the medication. Researchers say 26 patients have continued to respond over time, including some who have been on the drug for more than a year. One patient saw tumors disappear completely.

The drug also seems to work on a wide range of cancers, including some of the toughest to treat, including non-small cell lung cancer, melanoma skin cancer, colorectal cancer, kidney cancer and stomach cancer.

"This has all the characteristics of a really amazing drug," said Herbst, who has been testing new cancer medications for two decades. "I can count on one hand the number of times I've seen response rates like this."

The study was funded by Genentech/Roche, the company that is developing the drug. The results were presented at a Wednesday news conference organized by the American Society of Clinical Oncology in advance of its annual meeting, which starts May 31 in Chicago.

Study results presented at medical meetings are considered preliminary because they have not been subjected to the rigorous scrutiny required for publication in a medical journal.

At least four other companies -- Merck, Bristol-Mey
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Your immune system: On surveillance in the war against cancer
2. Immune Cell Discovery May One Day Lead to Herpes Vaccine: Study
3. Temple scientists weaken HIV infection in immune cells using synthetic agents
4. Estrogen fuels autoimmune liver damage
5. New findings on the brains immune cells during Alzheimers disease progression
6. Current HPV vaccine may not help some women with immune problems
7. UCLA, Caltech research on immune-cell therapy could strengthen promising melanoma treatment
8. Immune Therapy Shows Early Promise for Advanced Leukemia
9. Study reveals potential immune benefits of vitamin D supplements in healthy individuals
10. Delgado Protocol Announces Adrenal DMG, An Amazing New Supplement Designed to Support the Immune, Circulatory and Cardiovascular Systems
11. Evidence supports blocking immune response to enhance viral therapy against solid tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Drug May Help Immune System Fight Cancer
(Date:6/3/2015)... Vancouver personal injury lawyers at Jiwa ... now handle personal injury claims resulting due to bus ... more and more people turn towards mass transportation for ... suffering, serious injury and also deaths. , “If ... accident in BC you may have an ICBC Claim,” ...
(Date:6/3/2015)... 03, 2015 VeoMed and Decker ... online and mobile access to premier Continuing Medical ... of Certification (MOC) activities. , ... courses to Decker’s extensive lists of physicians, residents, ... access to VeoMed’s premier online and live-streamed courses. ...
(Date:6/3/2015)... Plano, Texas (PRWEB) June 03, 2015 ... Intelligence and Analytics solutions, today announced the launch ... Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio. ... embed additional visualization capabilities and advanced functionalities into ... of the DSX suite, Visual BI is adding ...
(Date:6/3/2015)... TN (PRWEB) June 03, 2015 According ... Inquisitr police officers intercepted fake oxycodone pills which ... pills were doctored to look legitimate, and even sported ... officers are warning those consuming 30 mg oxycodone to ... the pills online or buy them illegally on the ...
(Date:6/3/2015)... These are challenging and unpredictable times for traditional ... digital-first business are rewriting the rules for business as ... for traditional businesses to take on a more agile ... services. On top of this there is a ... to bring new innovation and approaches to business. , ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2
... more predominant in women, the reasons for this are ... on the risk and severity of RA, but the ... data from the Womens Health Initiative (WHI) clinical trials ... significant differences in the risk of developing RA or ...
... in Australian Research During an Event ... 2 April, PHILADELPHIA and LONDON, Feb. 28 ... ; TSX: TOC) and leading provider,of information solutions to ... honor Australia,s preeminent,researchers at the National Press Club in ...
... TAMPA, Fla., Feb. 27 Sirion Therapeutics, ... that its New Drug Application (NDA) for ... and Drug Administration (FDA) and granted,priority review. ... FDA for,its investigational compound Durezol(TM) (difluprednate ophthalmic,emulsion) ...
... Screening breast cancers for three receptors could help doctors ... A study published in the open access journal Breast ... negative for estrogen receptor (ER), progesterone receptor (PR) and ... appear to be most at risk from developing brain ...
... Revenues Up 38.8%, Nine-Month Revenues Up 40.6%, ETHEX Revenue ... Months Ther-Rx Revenue Up ... ST. LOUIS, Feb. 27 KV Pharmaceutical Company,(NYSE: ... and first nine months of fiscal 2008 ended December ...
... CORAL SPRINGS, Fla., Feb. 27 Boca Pharmacal, ... Administration has granted,final approval for the Company,s Abbreviated ... of Pamlab,s Palgic(R) Oral Solution,(Carbinoxamine Maleate Oral Solution) ... immediately., Carbinoxamine Maleate Oral Solution 4mg/5mL is ...
Cached Medicine News:Health News:Hormone replacement therapy appears to have no effect on risk and severity of rheumatoid arthritis 2Health News:Thomson Scientific To Honor Australia's Top Researchers With Dedicated Australian Research Day 2Health News:Thomson Scientific To Honor Australia's Top Researchers With Dedicated Australian Research Day 3Health News:Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation 2Health News:Breast cancer subtypes linked to survival from secondary brain tumors 2Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 2Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 3Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 4Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 5Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 6Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 7Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 8Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 9Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 10Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 11
(Date:6/3/2015)... AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ... today that their customer, Pharmabox, has introduced the world,s ... carries over 140 top selling brand name items typically ... Rite Aid-type store. As published in ... Miami -based Pharmabox worked with AVT to develop ...
(Date:6/3/2015)... , June 3, 2015  Flow cytometry ... around the globe and keeping track of wide-ranging ... competitive market. In particular, ensuring user-friendliness, fluorescence capabilities, ... are the most important factors influencing end-user purchase ... base. New analysis from Frost & ...
(Date:6/3/2015)... June 3, 2015 Varian Medical Systems (NYSE: ... selected to equip and service the new multi-room HollandPTC ... The company will book the equipment part of the ... HollandPTC is a key part of Medical Delta, the ... of Leiden, Delft and Rotterdam . ...
Breaking Medicine Technology:Pharmabox Introduces New Concept with a Boldly Designed Automated Retailing System 2Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 2Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 3Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 4Varian Medical Systems to Equip Proton Therapy Center in Netherlands 2Varian Medical Systems to Equip Proton Therapy Center in Netherlands 3
... Diagnostics Incorporated (NYSE: DGX ), the world,s leading ... Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), has extended ... shares of common stock of Celera Corporation (NASDAQ: ... p.m., New York City time, today, May 3, 2011, unless ...
... Calif., May 3, 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ... that it has entered into a definitive agreement with ... Life Sciences, to raise approximately $16.1 million in gross ... of common stock and warrants.  The Company agreed to ...
Cached Medicine Technology:Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today 2Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today 3Alexza Prices $16.1 Million Registered Direct Offering 2Alexza Prices $16.1 Million Registered Direct Offering 3Alexza Prices $16.1 Million Registered Direct Offering 4
Straight shaft with fine pointed 0.3mm Tips for Grasping Delicate Capsule; In Titanium....
12mm from bend to 0.12mm 1x2 teeth; In Titanium....
Straight Shafts with 0.12mm 1X2 Teeth With 5mm Tying Platform; In Titanium...
Gently curved 5mm Platform With 12, 0.12mm Teeth; In Titanium....
Medicine Products: